Translationally Relevant Oral Ruxolitinib Dosing Reduces Inflammation and Ameliorates Disease in Murine Models of Hemophagocytic Lymphohistiocytosis
- Resource Type
- Abstract
- Source
- In
Blood 5 November 2020 136 Supplement 1:21-21 - Subject
- Language
- ISSN
- 0006-4971